Salix Pharmaceuticals To Share New Data At Digestive Disease

/PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the...

Related Keywords

San Diego , California , United States , Canada , New Jersey , Quebec , Canadian , Lainie Keller , Christina Cheng , Research Posters , Bausch Health Companies Inc , Linkedin , Twitter , Lomb Corporation , Salix Pharmaceuticals , Exchange Commission , Comparator Solutions Across Clinical Trials , Prnewswire Bausch Health Companies Inc , Bausch Health , Health Companies , Digestive Disease Week , Plus Lactulose , More Efficacious , Lactulose Alone , Risk Reduction , Overt Hepatic Encephalopathy Recurrence , Subgroup Analysis , Alcohol Cirrhosis , New Trisymptom Composite Endpoint , Multiple Symptoms , Irritable Bowel Syndrome , Pooled Analysis , Two Randomized Phase , More Rapid , Sustained Clinical Response Compared , Adults Treated , Polyethylene Glycol , Based Bowel Preparation , Independent Predictor , High Quality Cleansing Success , Adults Undergoing Colonoscopy , Polyethylene Glycol Bowel Preparation , Nearly Doubles , High Quality Cleansing Versus Standard , Comparator Solutions Across Clinical , Chronic Idiopathic Constipation , Serious Dehydration , Prescribing Information , Bausch Health Companies , Canadian Securities Administrators ,